News By Tag
News By Location
Follow on Google News
Exploring the Implementation of Complex In-vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK
By: SAE Media Group
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Billion by 2028. The pharmaceutical industry globally is realising the growing potential of in vitro tissue models for drug discovery, pathology modelling and validation, safety, and toxicity.
3D Cell Culture technology promises to offer increased translatability in models and reduce the costly rates of drug attrition in the discovery process, heralding the next major advance in the discovery of pharmaceuticals.
The theme for this year's conference is Exploring the Implementation of Complex In-vitro Models for Drug Development.
The conference will be co-chaired by:
Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck and Rhiannon David, Director, Microphysiological Systems, AstraZeneca.
Interested partied can register at http://www.3d-
Featured Conference Speakers Include:
Key Reasons to Join Include:
Download the complimentary brochure at http://www.3d-
For sponsorship enquiries contact Andrew Gibbons on +44 (0) 207 827 6156 or email andrew.gibbons@
For media, press enquiries contact Simi Sapal on +44 (0) 207 827 6162 or email
3D Cell Culture Conference
8-9 February 2023
Sponsored: CelVivo, Promega and Systemic Bio
SAE Media Group Simi Sapal